Clinical Research Physician

Translational Research in Oncology•Atlanta, GA

6d•$110,000 - $150,000•Remote

About The Position

Translational Research in Oncology (TRIO) is a global academic clinical research organization dedicated to advancing translational cancer research in the clinical trial setting. Our passionate team is committed to providing cancer treatments of the future to the world of today. TRIO is looking for a Clinical Research Physician to join our Medical Monitoring Unit team . Reporting to the Medical Monitoring Unit Manager , this will be a home-based, full-time position in the USA.

Requirements

Medical Doctor degree required
Excellent knowledge and understanding of oncology and oncology clinical trials
At least 1 year of experience in medical monitoring in oncology trials
Current knowledge of ICH GCP guidelines
Advanced proficiency in MS Office in Word, Excel, and PowerPoint
Strong teamwork abilities and communication skills
Excellent level of English is required
Must be legally authorized to work in the country

Nice To Haves

Spanish language knowledge will be valued

Responsibilities

Act as Medical Monitor, performing comprehensive medical monitoring activities.
Respond to medical inquiries from investigational sites and trial teams.
Review patient eligibility and protocol deviations.
Oversee patient safety by reviewing medical data at patient and trial levels.
Review Serious Adverse Events (SAEs), including coding, causality and expectedness assessments, and drafting company comments.
Prepares scientific slides, attends and/or presents protocol information at Investigator Meetings, Scientific Committee meetings, Safety Review Committee meetings, SIVs, etc.
Serve as the primary clinical point of contact for scientific questions from internal and external stakeholders (e.g., IRBs, sites, sponsor medical teams, trial teams).
Collaborates with the Medical Writing and Training Unit to write and/or review trial-specific medical documents (e.g., protocols, DSURs, CSRs).
Conducting medical training on selected trial-specific or non-trial-specific topics.